Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi PEA Emergent EMEA (MSCI Emerging EMEA) ESG Transition UCITS ETF Acc

PLEM · FR0011440478 · class Acc · EUR · domicile France
Equity · Global · All sizes · Sustainable / ESGSFDR art. 8
Index tracked: MSCI EM EMEA Ex-Egypt ESG Broad CTB Select Index
TER
0.55%+ trans. 0.00%
Fund size
58 m EUR
Tracking difference
−1.08%3-year avg
🇮🇹 tax rate
white list not published
Replication
Synthetic (swap)
Income
Accumulating
Launch 5 May 2014 · costs from the KID as of 2 Sept 2026 · 29 securities held · 6 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · unofficial translation, the original prevails · 4 Aug 2026
The fund is a passively managed index-tracking UCITS. The investment objective of the Fund is to replicate, both upward and downward, the evolution of the MSCI EM EMEA Ex-Egypt ESG Broad CTB Select Index (the "Benchmark Index"), denominated in USD, while minimising the tracking error between the performance of the Fund and that of the Benchmark Index. The anticipated level of tracking error under normal market conditions is indicated in the Fund's prospectus. The Benchmark Index is based on the MSCI EM EMEA ex Egypt index, representative of the market…

Performance since series start (in euro) — base 100

5 May 20148 Sept 2026 · dividends reinvested where declared by the issuer
20152017201920212023202522592224
High 225 (28 Aug 2026) · low 92 (9 Feb 2016) · last 224. Past performance is not indicative of future results.

Returns in euro

1 year+20.3%
3 years+50.1%
5 years+27.6%
10 years+87.3%
Since series start+123.5%

Risk · 1 / 3 / 5 years

Volatility (ann.)14.68%13.41%14.59%
Max drawdown−11.36%−14.96%−23.75%
Sharpe1.160.830.24
Sortino1.811.190.34
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · PLEM · FR00114404781
RebalixPLEM · FR0011440478 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+15.11%+16.31%−1.20%
2024+12.77%+14.10%−1.33%
2023+7.89%+8.61%−0.71%
2022−15.24%−14.85%−0.39%
2021+4.37%+4.86%−0.49%

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 29 securities · top-10 weight = 59.0%
Top holdingsWeight
EDP SA9.0%
ORSTED A/S8.5%
DSV A/S (DKK)7.1%
JERONIMO MARTINS6.6%
VESTAS WIND SYSTEMS A/S5.5%
TELENOR ASA4.5%
NORSK HYDRO ASA NOK204.5%
GENMAB A/S4.5%
ISS A/S4.4%
FLSMIDTH & CO A/S4.4%

Listing venues

ESMA register (FIRDS) and official exchange lists
NK4T · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse Stuttgart, Tradegate Exchange
PLEM · Euronext Paris
+ 19 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/FR0011440478/FRA/FRA
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/FR0011440478/FRA/FRA/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/FR0011440478/FRA/FRA
The live sheet, always up to date
rebalix.com/en/etf/FR0011440478
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · PLEM · FR00114404782